Tampa, Florida 2021-09-17 07:44:19 –
Tampa, Florida — The Federal Pharmacy will discuss approval of booster shots of the Pfizer COVID-19 vaccine at a meeting on Friday.
A third shot is available for people with weakened immunity, but Pfizer is asking for the third shot to be added to the FDA’s official approval for people over the age of 16.
The Biden administration announced in August that it would like to make Moderna and Pfizer booster shots available to everyone over the age of 16 by next week. This is the case with FDA and CDC approval.
“”This new data confirms that vaccine protection remains high against the worst outcomes of COVID, but is concerned that this pattern of decline we see will continue in the coming months. “US surgeon General Vivek Murphy said at a briefing on August 18.”
Biopharmacy company Pfizer’s request mentions a lot of research, Says that their vaccines become less effective over time and contribute to breakthrough cases regardless of mutation.
According to one study, efficacy ranges from 96.2% 7 days after the second dose to 83.7% 4 months after the second dose.
“”Recently, we have found an increase in sexually transmitted infections in vaccinated people. What they are trying to do is restore the level of effectiveness of the vaccine against symptomatic infections, “USF medical professor Michael Teng told ABC Action News.
Ten believes the booster is worthwhile for people with weakened immunity and the elderly, but believes that 80% efficacy is not the time to start a third mass dose. He said he was. FDA approval required 50% effectiveness.
“People who are not vaccinated need to be vaccinated more than our immunity, which has been vaccinated,” said Teng.
“The delta mutation remains highly vaccine-effective against both symptomatic and severe disease. Therefore, current evidence does not appear to indicate the need for booster immunization in the general population.”
They say with Teng that they should first focus on giving the first and second doses to everyone in the United States and abroad.
“This pandemic doesn’t end until we get immunity worldwide,” Ten said. “We have a contract to buy a certain number of doses, but once that contract is fulfilled … the vaccine will be available in other countries, so we can afford to buy the vaccine. We can actually provide countries with access to vaccines. They can get vaccines now and buy large quantities of vaccines instead of us. “
The FDA Panel will discuss the data at a meeting on Friday and vote non-binding. From there, I’ll go to the CDC Advisory Board, which will meet next Wednesday and Thursday.
Pfizer requests FDA to approve booster vaccine for everyone 16+ Source link Pfizer requests FDA to approve booster vaccine for everyone 16+